U.S. Capital Markets Stock News

JFB Construction Holdings (JFB) has just posted another tough set of numbers for FY 2025, with Q3 revenue of US$5.0 million and a basic EPS loss of US$0.05, set against a trailing 12 month revenue decline of 20.4% and no net profit over the period. The company has seen quarterly revenue move from US$7.1 million in Q4 2024 to US$5.9 million in Q1 2025, US$3.7 million in Q2 2025, and US$5.0 million in Q3 2025. EPS shifted from a modest profit of US$0.02 per share in Q4 2024 to small gains in Q1...

NexPoint Real Estate Finance (NREF) just wrapped up FY 2025 with Q4 total revenue of US$30.0 million and basic EPS of US$0.67. Trailing twelve month revenue came in at US$157.3 million and EPS at US$4.28. Over the past year, the company has seen revenue move from US$73.1 million to US$157.3 million on a trailing basis, with EPS shifting from US$1.02 to US$4.28. This context allows investors to weigh these results against expectations. With margins running well ahead of the prior year, the...

Maui Land & Pineapple Company (MLP) opened FY 2025 with mixed quarterly numbers, reporting Q3 revenue of US$4.5 million and basic EPS of US$0.01, set against a trailing 12 month net loss of US$11.3 million on revenue of US$18.3 million. Over recent quarters, revenue has ranged from US$2.6 million to US$5.8 million per quarter, while basic EPS has moved between a loss of US$0.44 and a small profit of US$0.01 as reported for Q3 2025. For investors, the latest figures keep the spotlight on...

Phoenix Asia Holdings (PHOE) has just posted its H1 2026 scorecard, with trailing 12 month revenue of about US$7.4 million and net income of roughly US$1.0 million, translating to EPS of US$0.06, while the latest half year print for H2 2025 showed revenue of US$3.6 million and EPS of US$0.02. Over the last reported halves, the company has seen total revenue move from US$2.8 million in H2 2024 to US$3.8 million in H1 2025 and US$3.6 million in H2 2025, with EPS of roughly US$0.04 in both H2...

SEALSQ (LAES) just posted its FY 2025 first half numbers with revenue of roughly US$4.8 million and a basic EPS loss of US$0.17, against a trailing twelve month loss of US$0.38 per share on about US$11.0 million of revenue. Over the last three reported half year periods, revenue has moved between about US$4.8 million and US$6.2 million, while basic EPS losses ranged from US$0.17 to US$0.60. This has kept margins firmly in the red and put the focus squarely on how the business can turn growing...

Patriot National Bancorp (PNBK) just closed out FY 2025 with fourth quarter revenue of US$9.8 million and a basic EPS loss of US$0.02, alongside trailing twelve month revenue of US$28.1 million and a basic EPS loss of US$0.17. Over recent quarters the company has seen revenue move from US$4.7 million in Q2 2025 to US$7.6 million in Q3 2025 and then to US$9.8 million in Q4 2025. Quarterly basic EPS losses narrowed from US$0.21 in Q1 2025 to US$0.06 in Q2, US$0.03 in Q3 and US$0.02 in Q4...

AleAnna (NasdaqCM:ANNA) has just posted another quarter of rapid top line expansion, with Q3 FY 2025 revenue of about US$11.2 million and basic EPS of US$0.08, against a backdrop of very large revenue growth of 2,471.5% over the past year while remaining unprofitable on a trailing 12 month view. Over recent periods the company has seen revenue move from roughly US$0.6 million in Q3 FY 2024 to US$11.2 million in Q3 FY 2025, while trailing 12 month EPS across the last reported quarters stayed...

In its latest quarter, ASGN reported revenue and adjusted EBITDA margins ahead of expectations but missed EPS forecasts, while also outlining integration of the Quinnox acquisition and a rebranding to Everforth to consolidate its seven brands. This combination of earnings mixed with margin outperformance and a pivot toward higher-value consulting and unified branding could meaningfully reshape ASGN’s business mix and competitive positioning over time. We’ll now examine how ASGN’s Quinnox...

KULR Technology Group (KULR) closed FY 2025 with fourth quarter revenue of US$2.9 million and a basic EPS loss of US$0.97, alongside a trailing twelve month EPS loss of US$1.56 on revenue of US$16.2 million. Over the last few quarters, the company has reported revenue between US$2.4 million and US$6.9 million per quarter, while quarterly EPS has ranged from a loss of US$0.54 to a gain of US$0.22. This leaves investors focusing on how quickly these top line changes might translate into...

FitLife Brands (FTLF) has just closed out FY 2025 with fourth quarter revenue of US$25.9 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$81.5 million and EPS of US$0.68 that investors will be watching against the prior year’s figures. Over recent quarters the company has seen revenue move from US$15.0 million in Q4 FY 2024 to US$25.9 million in Q4 FY 2025, while quarterly EPS shifted from US$0.23 to US$0.17, setting the backdrop for the latest full year read on...

Check Point Software Technologies (CHKP) closed out FY 2025 with fourth quarter revenue of US$744.9 million and basic EPS of US$2.85, while full year trailing EPS reached US$9.85 on revenue of US$2.7 billion and earnings grew 25% over the past 12 months. Over the last few reported periods, revenue has moved from US$703.7 million in Q4 2024 to US$744.9 million in Q4 2025, with quarterly basic EPS ranging from US$1.77 in Q1 2025 to US$3.34 in Q3 2025 and trailing net income rising from US$845.7...

Dawson Geophysical (DWSN) closed out FY 2025 with fourth quarter revenue of US$26.9 million and basic EPS of US$0.02, alongside net income of US$0.6 million. This set a cleaner finish to a year where the trailing twelve month figures still show a loss of US$1.9 million on US$75.6 million of revenue and a basic EPS loss of US$0.06. Over recent quarters the company has seen quarterly revenue range from US$9.9 million to US$26.9 million, with EPS moving between a loss of US$0.08 and a profit of...

Alkermes (NasdaqGS:ALKS) has begun Phase 3 clinical trials for alixorexton, its orexin 2 receptor agonist for narcolepsy type 1 and type 2. The late stage Brilliance Studies aim to evaluate alixorexton in patients with significant unmet treatment needs in sleep disorders. This marks a new development in Alkermes' pipeline beyond prior focus areas highlighted in earlier coverage. For Alkermes, known for its work in neuroscience and psychiatry, the Brilliance Studies add a new dimension to...

Jiayin Group Inc. has reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of CNY 1,090.2 million and net income of CNY 100.63 million, alongside full-year revenue of CNY 6,222.19 million and net income of CNY 1,535.74 million. Alongside these results, the company increased its dividend payout framework to target around 30% of prior-year net income and completed a share repurchase of 4,600,000 shares, equal to 8.6% of its share count, signaling a stronger focus...

In the last week, the United States market has stayed flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. In this context, identifying stocks that might be undervalued based on current market estimates can offer investors opportunities to capitalize on potential growth while aligning with broader market trends.

In March 2026, Electronic Arts Inc was removed from the NASDAQ Internet Index, even as the company reported strong year-over-year EPS and revenue growth. Analysts have since raised their earnings estimates for EA, suggesting the index removal coincided with improving confidence in the company’s underlying profitability profile. With analyst earnings estimates moving higher, we’ll now examine how this renewed business momentum reshapes Electronic Arts’ broader investment narrative. The...

Core & Main (NYSE:CNM) has appointed former American Water Works CEO M. Susan Hardwick to its board, effective April 1. The company has restructured key governance roles, including a new board chair and a new audit committee chair. The longstanding executive chair has retired as part of the succession changes. Core & Main, trading at $49.4, is adjusting its leadership structure after a 3-year return of 121.8% and a 1-year return of 0.0%. The share price has seen a 2.3% decline over the past...

Ocugen (NasdaqCM:OCGN) completed enrollment and dosing early in its pivotal Phase 2/3 GARDian3 trial for OCU410ST. The trial evaluates a one time gene therapy candidate for Stargardt disease, a severe inherited retinal disorder with no approved treatments. This is Ocugen's second late stage clinical program and aligns with its stated goal to submit multiple BLAs by 2028. For readers tracking gene therapy names, Ocugen sits at the intersection of rare ophthalmology and inherited retinal...

Vera Therapeutics has appointed Jane Wright-Mitchell as its new Chief Legal Officer. Wright-Mitchell brings extensive legal, compliance, and intellectual property experience in life sciences and pharmaceuticals. The appointment adds senior leadership depth as Vera Therapeutics continues to develop its pipeline. The new Chief Legal Officer steps in at a time when Vera Therapeutics, listed as NasdaqGM:VERA, is trading at $40.23. The share price reflects a mixed return profile, with a 1.2%...

If you are wondering whether Sun Communities at around US$125.96 is offering fair value right now, you are not alone, many investors are asking the same question. The stock’s recent returns have been mixed, with a 2.2% decline over the last week, a 7.7% decline over the last month, but a 3.1% gain year to date and 4.8% over the past year. These moves come as Sun Communities continues to attract attention as a Residential REIT, with investors weighing its track record over the last 3 and 5...

FirstSun Capital Bancorp (NasdaqGS:FSUN) has been removed from the Russell 2000 Defensive Index. The company has also been dropped from the Russell 2500 Defensive, Russell 2500 Value-Defensive, and Russell 2000 Value-Defensive indices. This index reclassification affects how some passive and rules based funds may hold or view the stock. FirstSun Capital Bancorp, the holding company for FirstBank, operates as a regional banking platform focused on commercial and consumer financial services...

In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue and earnings expansion in alignment with these broader market trends.

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying stocks that are trading at a discount can offer potential opportunities for investors seeking value in a growing market.

In the last week, the United States market has stayed flat, yet it has risen by 16% over the past year with expectations of a 15% annual earnings growth in the coming years. In this context, identifying growth companies with high insider ownership can be advantageous as they often align management interests with shareholder value and may capitalize on favorable market conditions.